Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity
European Journal of Echocardiography , Volume 4 - Issue 4 p. 300- 305
Aims: To evaluate whether repetitive assessment of systolic and diastolic cardiac function by dobutamine stress echocardiography (DSE) can predict anthracycline cardiotoxicity. Methods and results: Thirty-one patients (age, 57 ± 13 years, 22 male) were studied before chemotherapy, with follow-ups during, at the end, and 6 months after chemotherapy. Left ventricular (LV) function was assessed by two-dimensional (2D) echocardiographic wall motion score index (WMSI) and by Doppler echocardiography of mitral valve inflow at rest and during DSE. Radionuclide ventriculography was used as an independent reference for ejection fraction (EF). A reduction of EF ≥5% occurred in 17 patients (group A) at the last follow-up. Patients without decreased EF comprised group B. Early/late diastolic velocity of mitral inflow (E/A ratio) at rest was lower in group A (0.91 ± 0.2 vs 1.28 ± 0.3, P < 0.001), and it was an independent predictor of cardiotoxicity (adjusted for baseline patient characteristics and parameters of systolic and diastolic function). At follow-up, WMSI at rest paralleled radionuclide EF. Contractile reserve at low-dose DSE was preserved in group A. Conclusions: WMSI measured by 2D echocardiography parallels radionuclide EF at follow-up. Assessment of contractile reserve has no incremental value for the early detection of cardiotoxicity. A baseline abnormal E/A ratio is an independent predictor of anthracycline cardiotoxicity.
|Anthracyclines, Dobutamine, Doppler, Drug toxicity, Echocardiography|
|European Journal of Echocardiography|
|Organisation||Department of Surgery|
Bountioukos, M, Doorduijn, J.K, Roelandt, J.R.T.C, Vourvouri, E.C, Bax, J.J, Schinkel, A.F.L, … Poldermans, D. (2003). Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. European Journal of Echocardiography, 4(4), 300–305. doi:10.1016/S1525-2167(03)00017-9